Kulagowski et al (1994) 3'-(Arylmethyl)- and
3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists
of the glycine site on the NMDA receptor. J.Med.Chem. 37 1402.
Obrenovitch and Zilkha (1996)Inhibition of cortical spreading
depression by L-701,324, a novel antagonist at the glycine site of the
N-methyl-D-aspartate receptor complex. Br.J.Pharmacol. 117 931.
Bristowet al (1996) The atypical neuroleptic profile of the
glycine/N-methyl-D-aspartate receptor antagonist, L-701,324 in rodents.
J.Pharmacol.Exp.Ther. 277 578. Bristowet al (1996)
Anticonvulsant and behavioral profile of L-701,324, a potent, orally active
antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor
complex. J.Pharmacol.Exp.Ther. 279 492.
Displays 26-fold and > 440-fold selectivity over kainate and NMDA receptors respectively. Neuro-protective; delays neuronal death in a global ischaemia model and cerebral infarction in a focal ischaemia model.